McHale Richard 4
4 · RESMED INC · Filed Apr 3, 2019
Insider Transaction Report
Form 4
RESMED INCRMD
McHale Richard
President, RC Business
Transactions
- Sale
ResMed Common Stock
2019-04-02$105.00/sh−21,616$2,269,680→ 23,404 total - Exercise/Conversion
Resmed Stock Option Plan
2019-04-01−1,079→ 21,616 totalExercise: $58.24From: 2016-11-11Exp: 2022-11-19→ ResMed Common Stock (1,079 underlying) - Exercise/Conversion
Resmed Stock Option Plan
2019-04-01−244→ 4,907 totalExercise: $58.24From: 2016-11-11Exp: 2022-11-19→ ResMed Common Stock (244 underlying) - Exercise/Conversion
Resmed Stock Option Plan
2019-04-02−21,616→ 0 totalExercise: $58.24From: 2016-11-11Exp: 2022-11-19→ ResMed Common Stock (21,616 underlying) - Sale
ResMed Common Stock
2019-04-01$105.05/sh−244$25,632→ 23,404 total - Exercise/Conversion
ResMed Common Stock
2019-04-01$58.24/sh+1,079$62,841→ 24,483 total - Sale
ResMed Common Stock
2019-04-01$105.05/sh−1,079$113,349→ 23,404 total - Exercise/Conversion
ResMed Common Stock
2019-04-02$58.24/sh+4,907$285,784→ 28,311 total - Sale
ResMed Common Stock
2019-04-02$105.00/sh−4,907$515,235→ 23,404 total - Exercise/Conversion
ResMed Common Stock
2019-04-02$58.24/sh+21,616$1,258,916→ 45,020 total - Exercise/Conversion
Resmed Stock Option Plan
2019-04-02−4,907→ 0 totalExercise: $58.24From: 2016-11-11Exp: 2022-11-19→ ResMed Common Stock (4,907 underlying) - Exercise/Conversion
ResMed Common Stock
2019-04-01$58.24/sh+244$14,211→ 23,648 total
Footnotes (2)
- [F1]The transaction was conducted under a Rule 10b5-1 plan.
- [F2]Represents date options first became exercisable. Options vest 1/3 per year.